| Symbol | IRME |
|---|---|
| Name | IR-MED INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 1231400 Israel Z.H.R Industrial Zone PO BOX 143 |
| Telephone | 972-4-655-5054 |
| Fax | — |
| — | |
| Website | http://www.ir-medical.com |
| Incorporation | US |
| Incorporated On | 2007 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Somekh Chaikin KPMG Israel; |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001839133 |
| Description | IIR-Med, Inc. and its consolidated Subsidiary, IR. Med Ltd. is an innovative med-tech company focused on leveraging Infra-Red light for medical application. IR-MED Inc. is developing a cutting-edge infrared spectroscopy and AI analysis technology platform as a basis for point-of-care decision support devices. The infrared spectroscopy technology allows harmless and non-invasive gathering of bio-information from patient blood and tissue. Bioinformation is then analyzed using the companys AI based process to provide healthcare professionals with decision support in the assessment of various medical conditions. PressureSafe, the companys first product based on this platform, is a handheld device designed to revolutionize the assessment of pressure injuries (PI) affecting skin and underlying tissue. Pressure Injury in the US alone accounts for $26.8B in healthcare spending and results in 60,000 deaths annually. PressureSafe is expected to contribute to assessment of pressure injuries, regardless of patient skin tone. This will drive equitable healthcare and help reduce the toll and cost of PI. IR-MED holds patents protecting its innovation in noninvasive tissue assessment. Additional info from OTC: |
No news found.